Real world evidence and pooled clinical trial data are becoming increasingly available, linkable and minable to find valuable insights quickly. As we evolve into a new era of data integration, biopharma companies stand to benefit enormously from bridging the experimental and post launch worlds of clinical data to support the entire product lifecycle.